{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:31:37Z","timestamp":1793413897270,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s43441-026-01027-6","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:33:58Z","timestamp":1785418438000},"page":"1811-1820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Generic Prednisolone Formulations on the Dissolution Behavior of Mycophenolate Mofetil under Various pH Conditions"],"prefix":"10.1007","volume":"60","author":[{"given":"Ryuto","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Shinotsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanon","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-4320","authenticated-orcid":false,"given":"Yusuke","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"1027_CR1","unstructured":"Ministry of Health, Labour and Welfare, Japan. Status of generic drug usage in Japan. Ministry of Health, Labour and Welfare; 2024 Oct 29. Available from: https:\/\/www.mhlw.go.jp\/stf\/newpage_44606.html"},{"key":"1027_CR2","unstructured":"Japan Generic Medicines Association. Generic drug use rate in Japan reached 82.7% in FY2023. Japan Generic Medicines Association; 2024 Aug 1. Available from: https:\/\/pj.jiho.jp\/article\/251419"},{"key":"1027_CR3","unstructured":"Ministry of Health, Labour and Welfare, Japan. NDB Open Data. Ministry of Health, Labour and Welfare. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html"},{"issue":"4","key":"1027_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13040235","volume":"13","author":"A Tsyplakova","year":"2025","unstructured":"Tsyplakova A, Catic-Djor\u0111evic A, Stefanovi\u0107 N, et al. Optimizing mycophenolate therapy in renal transplant patients using machine learning and population pharmacokinetic modeling. Med Sci. 2025;13(4):235.","journal-title":"Med Sci"},{"issue":"5","key":"1027_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.transproceed.2024.05.014","volume":"56","author":"LN Datrino","year":"2024","unstructured":"Datrino LN, Boccuzzi ML, Silva RM, et al. Safety and efficacy of mycophenolate mofetil associated with tacrolimus for kidney-pancreas and kidney transplantation: a systematic review and meta-analysis of randomized studies. Transplant Proc. 2024;56(5):1066\u201376.","journal-title":"Transplant Proc"},{"issue":"7","key":"1027_CR6","first-page":"945","volume":"43","author":"N Kimura","year":"2015","unstructured":"Kimura N, Suzuki T, Sobue S, et al. The bioequivalence between the original and the generic products of mycophenolate mofetil. Jpn Pharmacol Ther. 2015;43(7):945\u201354.","journal-title":"Jpn Pharmacol Ther"},{"issue":"23","key":"1027_CR7","first-page":"228","volume":"51","author":"H Hirano","year":"2016","unstructured":"Hirano H, Matsunaga T, Maenosono R, et al. Significant decrease of blood concentration after conversion of generic mycophenolate mofetil (MMF) in two cases of kidney transplant recipients. Jpa J Transplant. 2016;51(23):228\u201330.","journal-title":"Jpa J Transplant"},{"issue":"10","key":"1027_CR8","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1016\/j.transproceed.2018.04.064","volume":"50","author":"H Hirano","year":"2018","unstructured":"Hirano H, Matsunaga T, Maenosono R, et al. Effect of systematic conversion to generic mycophenolate mofetil (MMF) in kidney transplantation: a single-center clinical experience from Japan. Transplant Proc. 2018;50(10):3255\u20137.","journal-title":"Transplant Proc"},{"issue":"4","key":"1027_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/17411343241298828","volume":"20","author":"Y Takizawa","year":"2024","unstructured":"Takizawa Y, Kanatani S, Oishi K, et al. Comparison of dissolution profiles of brand and generic drugs of mycophenolate mofetil in the presence of concomitant drugs. J Generic Med. 2024;20(4):196\u2013206.","journal-title":"J Generic Med"},{"key":"1027_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124179","volume":"659","author":"MR Woo","year":"2024","unstructured":"Woo MR, Bak YW, Cheon S, et al. Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib. Int J Pharm. 2024;659:124179.","journal-title":"Int J Pharm"},{"issue":"1","key":"1027_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.xphs.2024.09.020","volume":"114","author":"TN Hiew","year":"2025","unstructured":"Hiew TN, Solomos MA, Kafle P, et al. The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations. J Pharm Sci. 2025;114(1):289\u2013303.","journal-title":"J Pharm Sci"},{"issue":"11","key":"1027_CR12","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","volume":"14","author":"B Xie","year":"2024","unstructured":"Xie B, Liu Y, Li X, et al. Solubilization techniques used for poorly water-soluble drugs. Acta Pharm Sin B. 2024;14(11):4683\u2013716.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"1027_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050598","volume":"17","author":"MR Qelliny","year":"2025","unstructured":"Qelliny MR, Mustafa WW, Al Fatease A, et al. Biofunctional excipients: their emerging role in overcoming the inherent poor biopharmaceutical characteristics of drugs. Pharmaceutics. 2025;17(5):598.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1027_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm93020019","volume":"93","author":"V B\u00e1rdos","year":"2025","unstructured":"B\u00e1rdos V, Szoll\u00e1th R, T\u0151zs\u00e9r P, et al. Study of the influence of pharmaceutical excipients on the solubility and permeability of BCS class II drugs. Sci Pharm. 2025;93(2):19.","journal-title":"Sci Pharm"},{"issue":"18","key":"1027_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/polym17182484","volume":"17","author":"I Pantazos","year":"2025","unstructured":"Pantazos I, Poimenidou M, Kouskouridas D, et al. Influence of drug properties, formulation composition, and processing parameters on the stability and dissolution performance of amorphous solid dispersions-based tablets. Polymers (Basel). 2025;17(18):2484.","journal-title":"Polymers (Basel)"},{"issue":"3","key":"1027_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.14712\/23362936.2024.18","volume":"125","author":"S Merdita","year":"2024","unstructured":"Merdita S, Ry\u0161\u00e1nek P, Hartinger JM, et al. Pharmacokinetic-based dosing individualization of mycophenolate mofetil in solid organ transplanted patients. Prague Med Rep. 2024;125(3):187\u201394.","journal-title":"Prague Med Rep"},{"key":"1027_CR17","first-page":"64","volume":"20","author":"JW Moore","year":"1996","unstructured":"Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol. 1996;20:64\u201374.","journal-title":"Pharm Technol"},{"key":"1027_CR18","unstructured":"FDA guidance for industry, Dissolution testing of immediate release solid oral dosage forms, August, 1997."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01027-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:02:59Z","timestamp":1793412179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01027-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01027-6","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not include any studies that require ethical approval.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}